Law offices of howard g. smith encourages regeneron pharmaceuticals, inc. (regn) investors to inquire about securities fraud class action

Bensalem, pa.--(business wire)--law offices of howard g. smith announces that a class action lawsuit has been filed on behalf of investors who purchased regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn) securities between november 2, 2023 and october 30, 2024, inclusive (the “class period”). regeneron investors have until march 10, 2025 to file a lead plaintiff motion. if you are an investor who suffered a loss in regeneron pharmaceuticals, inc. (regn), contact the l.
REGN Ratings Summary
REGN Quant Ranking